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Pathological studies of early Guillain-Barré syndrome (GBS), defined as of 10 days of 
disease onset, are scanty making it difficult to interpret the physiopathology of clinical 
and electrophysiological features. In 1949, Webb Haymaker and James Kernohan 
reported 50 clinico-pathological studies of fatal GBS cases, 32 of them having died 
between days 2 and 10 after onset. They established that the brunt of initial lesions, 
consisting of endoneurial oedema interpreted as degenerative, relied on spinal nerves. 
That this oedema was inflammatory was soon thereafter recognized. Two decades later, 
however, the pathogenic role of endoneurial oedema was disputed. In experimental 
allergic neuritis, considered an animal model of GBS, the initia l lesion appearing on day 
4 post-inoculation is marked inflammatory oedema in the sciatic nerve and lumbosacral 
nerve roots. Additional detailed clinico-pathological studies corroborated that the 
appearance of epi-perineurium at the subarachnoid angle, where anterior and posterior 
roots join to form the spinal nerve, is a pathological hotspot in early GBS, there 
developing inflammatory oedema, incipient demyelination and endoneurial ischemic 
zones with axonal degeneration. Furthermore, nerve ultrasonography has demonstrated 
predominant spinal nerve changes in early GBS, either demyelinating or axonal. Other 
outstanding Haymaker and Kernohan’s contributions were to clarify the complex 
nosology of the syndrome bringing under the same rubric Landry’s paralysis, acute 
febrile polyneuritis and GBS, and critically analyzing GBS exclusion criteria by then 
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Almost seven decades ago, Haymaker and Kernohan reported a clinico-pathological 
study in 50 cases of fatal Guillain-Barré syndrome (GBS), 32 of them having died 
between 2 and 10 days after symptomatic onset, namely during the period currently 
accepted as early GBS [1]. The authors found that the brunt of initial lesions, consisting 
of endoneurial oedema interpreted as degenerative, relied on spinal nerves. Remarkably, 
these features have been most important to understanding the physiopathology of the 
disease. At the time of publication, the paper was also essential to clarify the 
nosological limits of GBS with Landry’s palsy and acute febrile polyneuritis (AFP). The 
aim of this paper is to carry out a review of Haymaker and Kernohan’s contributions to 
the knowledge of GBS. For this purpose, there will be two introductory paragraphs 
devoted to overview the disorder with emphasis on its early stage, followed by a 
historical revision of the original descriptions of GBS, Landry’s palsy and AFP, and the 
landmark paper by Haymaker and Kernohan. Subsequently, the key role of early 
endoneurial inflammatory oedema will be analyzed through reported pathologica l 
papers on GBS and experimental allergic neuritis (EAN), and more recently by means 
of nerve ultrasonography (US). This review provides evidence that spinal nerve 
involvement is a hotspot for early GBS. 
 
2. Brief overview of the present GBS nosology 
GBS is an acute-onset, immune-mediated disorder of the peripheral nervous system, 
which is currently divided into several subtypes based on electrodiagnostic, pathological 
and immunological criteria [2-6]. GBS includes at least three disease patterns: acute 
inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal and motor-















pathologically characterized by demyelination and inflammatory infiltrates in spinal 
roots and nerves [8, 9]; in a variable proportion of cases, however, demyelination is 
accompanied or substituted by axonal degeneration [10-14]. AMAN is a pure motor 
disorder frequently associated with serum antibodies against gangliosides, GM1, GM1b, 
GD1a or GalNAc-GD1a, and antecedent of Campylobacter jejuni enteritis [2-6]. 
Autopsy studies in AMAN have revealed axonal degeneration of motor fibres without 
demyelination, indicative that there may be an immune response directed primarily 
against the motor axolemma; it is now established that carbohydrate mimicry between 
bacterial lipo-oligosaccharide and human gangliosides is an important cause of AMAN. 
It is worth noting that in the early AMAN pattern, predominant wallerian-like pathology 
usually occurs within 200 µm of the ventral root exit zone, the stage of this pathology 
being more advanced in the roots than in the peripheral nerves [7, 15-17]. In Europe and 
North America, GBS is usually caused by AIDP, whereas in East Asia a considerable 
number of GBS patients have AMAN or AMSAN [5, 7, 15-18]. The Fisher’s syndrome 
is especially associated with antibodies to GQ1b and characterized by the triad of acute 
ophthalmoplegia, ataxia and areflexia. The GBS crude average annual incidence rate in 
our Community (Cantabria, Spain) was 0.95 cases per 100,000 population (95% CI: 
0.72-1.17) [19]. 
 
3. GBS diagnosis with emphasis on its early stage 
Most patients will have an acute neuropathy reaching a peak within 4 weeks of onset, 
and this progressive weakness is one of the core diagnostic clinical features of GBS [2-
3]. At the nadir of the disease, the clinical diagnosis of GBS is not difficult for the 
trained clinical neurologist and relies on diagnostic criteria having stood the test of time 















onset [21], when atypical clinical signs and symptoms may lead to delayed diagnosis 
[22]. Neurophysiological testing plays a very important role in confirming the diagnosis 
of peripheral neuropathy and GBS subtype classification, though syndromic subtyping 
may require serial studies [23-26]. It is a rooted concept that electrical abnormalities in 
GBS may not be sufficiently widespread for definite diagnosis in the first 2 weeks [10]. 
Involvement of proximal nerve trunks, including spinal roots, spinal nerves and 
plexuses, is an important nosological notion in early GBS for the following reasons: i/ 
weakness may initially be proximal in 58% of cases [27], a sign that cannot be 
accounted for by distal nerve segment pathology; ii/ often there is inaugural severe 
nerve trunk pain that may be accompanied by a Lasègue’s sign or neck and back 
stiffness, these manifestations having been correlated with swollen nerve roots [15, 16, 
27-31]; iii/ elevated cerebrospinal fluid (CSF) protein concentration is characteristic of 
the syndrome, even in the first few days of the clinical course, and explained as the 
result of breakdown of the radicular blood-CSF barrier [27]; and iv/ in a significant 
proportion of patients, initial electrophysiology shows just abnormal late responses (F 
waves and H waves) pointing to a dysfunction of proximal nerve segments [32, 33]. 
 
4. Original description of GBS: from Guillain, Barré and Strohl to Haymaker and 
Kernohan 
In the “Séance de la Société Médicale des Hopitaux de Paris” held on 13 October 1916, 
Guillain, Barré and Strohl reported the case of two soldiers with acute paralysis 
admitted, during the Battle of the Somme, to the Neurological Centre of the French 
Sixth Army (Amiens) [34]. The first patient was a hussar, aged 25 years, hospitalized on 
25 August 1916 with a 25-day history of progressive pins and needles and weakness of 















absent tendon reflexes and mild sensory loss. There was rapid recovery, so the patient 
was discharged on September 30. The second patient was a 35-year-old infantryman 
with an 8-day history of erratic limb pains and progressive weakness initiated in lower 
limbs. The authors’ eloquent description is as follows: “Le quatrième jour il veut partir 
vers cinq heures avec ses camarades, s’équipe mais tombe à la renverse avec sa musette 
et ne peu se relever” (On the forth day, at 5:00 hours, he wanted to set off with his 
comrades, put on his military equipment, but fell over backwards and was unable to 
stand up). Again no preceding illness was reported. On admission, 5 September 1916, 
there was severe tetraparesis and bilateral facial palsy, absence of lower-limb reflexes 
evolving to generalized areflexia, and slight glove and stocking hypoesthesia. The 
patient improved in the following days, he being transferred to a rearguard area on 
October 4. In both cases CSF examination revealed albumino-cytological dissociation, a 
finding that, as underlined by the authors, had been described only in association with 
compression of the spinal cord and with Pott’s disease. The authors carried out graphic 
records of the knee and ankle reflexes, which showed delayed responses to almost twice 
the normal latency. Based upon these findings, they concluded that the syndrome 
seemed to result from a concomitant attack on the spinal roots, nerves and muscles, 
probably by an infectious or toxic agent. As of 1927, the illness was recognised with the 
eponym Guillain-Barré syndrome [35]. 
It is worth noting that the original report by Guillain and colleagues did not 
contain any assessment of the literature [34]. At that time, however, two comparable 
nosological entities, Landry’s palsy and acute febrile polyneuritis (AFP), had already 
been reported, which are briefly commented on below. 
In 1859, Octave Landry described 10 cases of acute ascending paralysis and 















their autopsies failing to demonstrate the cause of illness after examination of brain and 
spinal cord and muscles; apparently the peripheral nerves were not examined. The 
remaining eight patients exhibited remission of the illness. These cases fitted well with 
the modern concept of GBS, but necessarily lacked the defining features of tendon 
areflexia and CSF albumino-cytological dissociation [37]. 
AFP is an entity introduced by Osler in 1892 to designate an illness starting with 
a temperature rapidly rising to 103ºF or 104ºF (39.5ºC or 40ºC) and causing aching 
limbs and back, tingling and ascending or descending paralysis with respiratory 
involvement, some patients dying and others remaining stable for several weeks and 
then slowly recovered [38]. According to the author the clinical picture is not to be 
distinguished, in many cases, from Landry’s paralysis. Holmes described 12 patients of 
AFP coming from British Army in France, who were attended in winter of 1916-1917 
[39]. In this series invariably there was facial paresis, deep tendon areflexia and 
sphincter disturbances, though the use of a catheter was never necessary. CSF in three 
cases was normal. Two patients died, one from bronchitis and the other from 
bronchopneumonia, the remaining 10 patients showing rapid improvement. Autopsy in 
both fatal cases revealed no findings in the central nervous system, and demyelination 
of the sciatic nerve in the only case with sampled peripheral nerves. Wisely, Holmes 
wrote: “Unavoidable circumstances made a more complete examination of the nervous 
system impossible, but these changes are sufficient to confirm the diagnosis of 
peripheral neuritis”. Holmes’ report did not contain any assessment of the literature 
either. 
The nosology of “radiculoneuritis with acellular hyperalbuminosis of the CSF” 
was updated by Georges Guillain himself, reviewing 27 reports published between 1916 















pronounced CSF hyperalbuminosis is a constant feature, which characteristically ranges 
“From 1 to 2 Gm. per 100 cubic centimetres… Cases with slight hyperalbuminosis, with 
an albuminoid content from 0.3 to 0.4 Gm., do not belong to the syndrome or must be 
regarded as instances of an abortive form”. As stated by Wiederholt and colleagues, in 
all probability the values reported by Guillain as grams per 100 millilitres were meant 
by the author to be grams per litre [41]. Additional features of the syndrome would be 
abolition of tendon reflexes, and favourable clinical course; in fact, Guillain considered 
that two previously reported fatal cases “did not belong to this group”. Furthermore, 
Guillain considered that Landry’s paralysis and AFP are dissimilar entities. 
 
5. The Landry-Guillain-Barré syndrome: the landmark contribution by Haymaker 
and Kernohan 
In an 82-page paper with 225 references, Haymaker and Kernohan carried out an 
exhaustive review of the literature of GBS, Landry’s paralysis and AFP, and described 
50 fatal GBS cases, 32 of them having died between 2 and 10 days after symptomatic 
onset, received in the U.S. Army Institute of Pathology during World War II [1]. For the 
first time in the literature, GBS, Landry’s paralysis and AFP were considered to fall into 
a single category; in fact, the name of Landry was included in the title of their paper. 
Worthy of note is that this terminology met with the opposition of some French authors 
who wrote: “Cette terminologie qui est apparue depuis la publication de Haymaker et 
Kernohan (1949) est erronée et elle fait perdre à chacun des éponyms toute leur 
signification”  (this terminology appeared after Haymaker and Kernohan’s publication is 
wrong, since each eponyms lose their significance) [42]. The authors carried out an 
update of the significance of the increase in protein in the CSF, as set out by Guillain 















the onset of the illness, protein becoming elevated in the course of the disease. 
Furthermore, they added: “were Guillain’s criteria strictly adhere to, one would be 
obliged to remove from consideration many cases in the literature designated by the 
term Guillain-Barré syndrome”. 
Concerning mortality, Haymaker and Kenohan quoted a sentence by Guillain, 
who, in a symposium on the subject held in Brussels in 1938, stated that the disorder 
described by him might be fatal; very pertinently the authors wrote “a concession which 
seems to have escaped the notice of most subsequent workers on the subject”  [1]. 
Detailed clinical data, including positive, negative and not available information, 
is summarized in table 4 occupying 12 pages [1]. In their autopsy studies, the authors 
found that the most profound GBS alterations were encountered in the peripheral 
nervous system. Starting from the 32 early GBS histological studies, they were able to 
describe the topography and evolution of initial lesions as follows: “As a whole, the 
observed pathological changes were more prominent in the region where motor and 
sensory roots join to form the spinal nerve. Oedema of the more proximal part of the 
peripheral nervous system constituted the only significant alteration the first 3 days of 
illness. By the fourth day, slight swelling and irregularity of myelin sheaths were 
detected, and by the fifth, clear-cut disintegration of myelin and swelling of axis 
cylinders. On the ninth day a few lymphocytes sometimes began to appear, on the 
eleventh, phagocytes, and on the thirteenth, a proliferation of Schwann cells…The most 
severe changes were noted in the cases of longest duration, namely 46 days… In all the 
cases in which appropriate material was available, the degenerative changes, decidedly 
focal in early stages of the disorder, were concentrated in the region of the spinal nerves 
and extended both proximally and distally for a short distance, but whether or not 















the paucity of peripheral nerve material. Where motor symptoms were most prominent 
the lesions tended to predominate in the anterior roots, and where widespread 
anaesthesia accompanied the paralysis the lesions were found in anterior and posterior 
roots”. Given that lymphocytes tended to increase in number as time went on, they were 
originally regarded as part of a reparative process; in fact, the disorder was 
characterized by a “polyradiculoneuropathy”, in which changes in the amount of protein 
and in the number of cells in the CSF were regarded as incidental to the disorder. 
Central chromatolysis was observed in spinal motor neurons and dorsal ganglion 
neurons, a feature that would be widely confirmed in further works; worthy of note is 
the observed presence of inflammatory cells in spinal and sympathetic ganglia. 
Separately, the authors reported two clinico-pathological studies in GBS patients [43, 
44], which are briefly analysed hereafter.  
Gilpin, Moersch and Kernohan analysed 35 cases of acute polyneuritis, 15 them 
being removed from consideration because of lack of CSF complete examination [43]. 
Clinical data of the remaining 20 cases are fully and timely tabulated. Most patients had 
an increase of CSF proteins (100 to 800 mg. per 100 cc), cells, mostly lymphocytes, 
varying between 1 and 80 per cubic millimetre (average 12). Although the authors 
recognized closely similarity to AFP and without referring to the paper by Guillain and 
colleagues [34], they used the term “neuronitis” to designate the disease. Such 
designation generated sharp comments (see remarks following the Discussion of the 
paper): i/ Adolph Meyer (Baltimore) stated: “To speak of neuronitis is a little awkward. 
One ought to have the term for the primary alterations of nerve elements”; and ii/ and 
Israel Wechsler (New York) annotated: “Therefore, I think that the name polyneuritis -
not neuronitis, which is a barbarous word- should be applied in these cases and not in 















patient 3, showing a typical GBS with facial diplegia, who died one month after 
admission, and whose histological study included central nervous system, spinal roots, 
cranial, phrenic, intercostal, sciatic and femoral nerves, brachial plexus, sympathetic 
nervous system, and gasserian and dorsal root ganglia. As a whole, there was 
widespread and patchy demyelination of peripheral nerves with marked endoneurial 
oedema separating the fibres. It is worth noting the presence of beautiful images of 
fragmentation and vacuolation of axis-cylinders stained by a modified silver 
impregnation method. The authors wrote that “there were a few lymphocytes in the 
nerves, but seemed to us that these could be accounted for on basis of degeneration 
rather than on true inflammation”. In this regard, it should be pointed out that paraffin 
sections, at that time used, may reveal minor or no inflammatory changes [45, 46]. Be 
that as it may, Gilpin and colleagues described that “in the bundles distal to the ganglia 
there were collections of lymphocytes, and many were also scattered diffusely 
throughout the connective tissue which presented marked oedema”; furthermore their 
figure 4 shows marked subacute inflammatory process involving the fifth cranial nerve 
just distal to the gasserian ganglion. In retrospect, this study shows many of the 
pathological features characterizing the modern concept of AIDP. 
In 1955, Waskman and Adams described EAN produced by injecting rabbits 
with rabbit sciatic nerve or spinal ganglia [47]. The authors indicated that this 
experimental disease is of importance because it represents one of the first laboratory 
models of non-infectious inflammatory disorder of peripheral nerves; they rightly noted 
resemblances between EAN and GBS. Thereafter, Matsuyama and Haymaker reported a 
clinico-pathological study in a fatal GBS case died on day 15 after onset, corroborating 
the topography of changes in peripheral nervous system including sympathetic white 















infiltrates with presence of myelin debris in enlarged Schwann cells, though failed to 
interpret the primary pathogenic role of nerve inflammation. 
In short, the contributions by Haymaker and Kernohan could be summarized as 
follows: i/ ascending Landry’s paralysis, AFP and GBS are similar disorders; ii/ neither 
albumino-cytological CSF dissociation nor fatal evolution is a criterion of exclusion of 
GBS; iii/ in early GBS the brunt of pathology relies on proximal nerve trunks, and 
particularly where motor and sensory roots join to form the spinal nerve; and iv/ initial 
lesions consist of endoneurial oedema, reparative inflammatory cells not appearing till 
later stages of the clinical course. 
 
6. Krücke corroborates the relevance of spinal nerve pathology in GBS 
In his GBS autopsy material (3 infantile cases and 4 adult cases), Krücke carried out a 
systematic study of the central and peripheral nervous system, including proximal and 
distal nerve trunks and sympathetic system (Fig. 1A) [48]. In this material, endoneurial 
infiltrates occurred as of 24 hours and were prominent as of the third day. Endoneurial 
oedema was accompanied by cellular infiltrates; given that there were no isolated serous 
exudates, as previously reported [1, 43], the author interpreted that oedema was an 
integral part of the inflammatory process. Parenchymal destruction, namely, 
demyelination, was most prominent as of day 14. Initially, lesions were focal 
predominating in proximal nerve trunks, particularly in spinal nerves where oedema 
was severe enough to cause their swelling visible to the naked eye (Fig. 1B, 1C). As 
illustrated in Fig. 2, the severity of spinal nerve inflammatory lesions was variable. It is 
worthy of note that comparable inflammatory infiltrates involved sympathetic nerves, 
















7. Neither pre-inflammatory nor oedema stage in GBS? 
Asbury and colleagues reported another comprehensive clinico-pathological series of 19 
GBS patients, cases 1-5 being autopsied within 9 days after onset [8]. The authors 
established that the pathologic hallmark of the disease is a spotty perivenular 
mononuclear inflammatory infiltrate with segmental demyelination being the 
predominant form of nerve fibre damage. According to the authors, all levels of the 
peripheral nervous system are vulnerable to attack, including the anterior and posterior 
roots, ganglia, proximal and distal nerve trunks and terminal twigs, cranial nerves, and 
sympathetic chains and ganglia. In contrast to what described Haymaker and Kernohan 
(vide supra), no pre-inflammatory or oedema stage was recognized either in the gross or 
microscopic state. They stated that some of the emphasis on root pathology doubtlessly 
reflects the fact that roots have been taken at the autopsy table far more frequently than 
have peripheral nerves; no level or site in the peripheral nerve is indemnified. Although 
this notion is probably true in the long run of the clinical course [9], it is worth noting 
that in 2 cases (Nos. 2 and 3) presenting with motor clinical manifestations, lesions 
predominated in anterior roots, peripheral nerves being minimally involved. Moreover, 
case 2 showed prominent axonal retraction bulbs on silver stains in lumbar roots, which 
pertinently the authors related with intense inflammatory changes. This patient, that had 
had an influenza- like illness 10 days prior to admission, probably represents the first 
description of AMAN. Finally, Asbury and colleagues underlined the similarities 
between EAN and GBS, which are helpful in understanding the events surrounding the 
onset of GBS and interpreting its pathology.  
In the Foreword of a recent book on peripheral neuropathy, Asbury commented 
on the influential paper by Haymaker and Kernohan [1], stating that the gist of their 















they studied until the eighth day of illness, this being interpreted as a reparative change 
[49]. Asbury argues as follows: “This was in accord with the prevailing English-
language view of the pathology of the Landry-Guillain-Barré syndrome in the mid-20th 
century, namely that GBS was an acute, bland process, affecting mainly the spinal roots 
but that did not excite an inflammatory response. In contrast, some French and German 
neuropathologic observers had long noted widespread inflammatory changes in 
peripheral nerve, ganglia and spinal roots, but the inflammatory changes were either not 
recognized or were misinterpreted by many others, especially by English and North 
American observers”. Even though Asbury was well aware of the aforementioned paper 
by Krücke [48], he avoided discussing the relevance of florid spinal nerve pathology 
reported in GBS (vide supra). 
 
8. Inflammatory oedema of proximal nerve trunks is a relevant feature of EAN 
In the seminal paper on EAN mediated by T cell lines specific for bovine P2 protein, 
Izumo and colleagues reported that the initial lesion, appearing on day 4 post-
inoculation (pi), is marked oedema with or without cellular infiltrates in the sciatic 
nerve and lumbosacral nerve roots [50]. On the following day, extensive, disseminated 
lesions were observed in the sciatic nerve, these being more severe and advanced 
proximally. They consisted of marked oedema, cellular infiltrates, and perivascular 
cuffs not only in the endoneurial space but also in the epineural connective tissue; there 
appeared incipient demyelination that was more obvious as of day 7 pi. Between days 7 
and 8 pi and independent of demyelination, there were some nerve fibres showing 
distinct evidence of axonal degeneration. Potential mechanisms of axonal degeneration 
in EAN and GBS were discussed by Izumo and colleagues, who wisely wrote: “In our 















intense endoneurial oedema. This observation would support the possible role for 
ischemia in the development of axonal degeneration”. Our pathological studies in GBS 
prove the validity of such proposal (next paragraph). 
 
9. Spinal nerve epi-perineurium contributes to axonal damage in GBS 
In three clinico-pathological studies carried out in severe AIDP patients, we have 
demonstrated that the lesional pattern drastically changes in the transition from 
preforaminal nerve roots to post-foraminal nerve trunks [51-53]. Our contributions are 
summarized herebelow. 
In a fulminant AIDP patient, aged 67 years, who died on day 18, 
electrophysiology showed universal nerve inexcitability on days 3, 10 and 17 [51]. 
Histological study showed widespread inflammatory demyelination of spinal roots, and 
predominantly axonal degeneration of peripheral nerve trunks (Fig. 3). This dissociated 
pattern of pathology between spinal roots and more distal nerve trunks, which was 
hitherto unheard-of in human pathology, had already been reported in EAN induced by 
P2 peptide [54]. In EAN, the severity of lesions correlates with the dose of peptide 
inoculates; low doses result in pure demyelination, whereas axonal degeneration occurs 
with high doses of antigen. In spite of widespread inflammation, axonal damage in this 
EAN model was severe in sciatic nerve and almost absent in lumbosacral roots, just as 
we had observed. Furthermore, in this EAN model axonal degeneration was 
centrofascicular [55], namely, a feature characteristic of ischemic neuropathy [56]. 
Based upon these features and Izumo’s insights into the mechanisms of axonal damage 
in EAN (vide supra), we proposed the hypothesis of increased EFP in nerve trunks 
possessing epi-perineurium as the cause of axonal pathology in early stages of severe 















more distant nerve trunks to establish whether or not the appearance of epi-perineurium 
determines any change in the degree of axonal degeneration. It is timely to remember 
that spinal roots traverse the subarachnoid space covered by an elastic multicellular root 
sheath derived from the arachnoid angle (Fig. 4) [57]. External to this angle, nerve roots 
(spinal nerves) possess epi-perineurium and endoneurium as in the peripheral nerve 
trunks [58]. We hypothesized that if Haymaker and Kernohan [1] were right in their 
appreciation of maximum oedema (inflammatory oedema according to Krücke [48]; 
vide supra) on spinal nerves in early GBS, this could result in focal increase of EFP 
leading to ischemic changes and proximal conduction failure. This question was 
addressed in two clinico-pathological studies [52, 53]; briefly, I will focus on the first 
one in the next paragraph. 
A patient, aged 79 years, presented with 2-day history of distal paresthesias and 
ascending weakness culminating in quadriplegia and mechanical ventilation; he died 60 
days after onset [52]. Serial electrophysiological studies (days 4, 17 and 50) initially 
showed normal nerve conduction velocities with further slowing down to the 
demyelinating range, progressive attenuation of compound motor action potentials 
(CMAP), absent sensory nerve action potentials, and profuse muscle denervation. 
Pathological study included preforaminal anterior and posterior L5 spinal roots, third 
and fifth lumbar spinal nerves and their branches, and femoral and sural nerves. Mild 
de/remyelination was noted in lumbar roots. Axonal degeneration was the predominant 
lesion in sural nerve. In both lumbar nerves and their branches, there were extensive 
de/remyelination, and centrofascicular or wedge shaped areas with marked loss of large 
myelinated fibers (figure 5). Such focal endoneurial lesions are characteristic of nerve 
ischemia involving watershed zones of poor perfusion [56]. In EAN, axonal damage in 















which is correlated with an increase of EFP causing constriction of transperineurial 
vessels with pathogenic diminution of nerve blood flow [59]. We argued that the 
absence of epi-perineurium in spinal roots probably prevents their having an increase of 
EFP and ischemic injury in spite of inflammatory demyelination. Perineurium is 
relatively inelastic and has only a limited ability to expand. Small increases of EFP, as 
caused by endoneurial inflammation [50, 56, 59], can be accommodated, but any 
increase beyond these limits, as presumably occurs in early stages of severe or 
fulminant forms of GBS, will produce an increase in EFP, leading to distal axonal 
degeneration (see Fig. 4). Parallel to the distribution of endoneurial inflammatory 
changes, nerve ischemia could account for early partial or complete conduction block or 
even for universal inexcitability [51, 60]. Despite accumulation of ischemic areas 
distally, it is conceivable that just partial preservation of one or several nerve fascicles 
could explain attenuated CMAP with normal motor conduction velocity, as occurred at 
first electrophysiological evaluation of the current patient. Quick clinical recovery, 
occasionally reported in other GBS cases, could be related to the fact that conduction is 
rapidly re-established with restoration of nerve flow in nerves suffering ischemic axonal 
dysfunction, but without getting Wallerian-like degeneration [56]. Obviously, our 
pathogenetic proposal does not exclude the contribution of primary myelin or axonal 
pathology to early electrophysiological abnormalities. Later electrophysiologic features 
will rely on such myelin, axonal, or both pathologies. 
 
10. Spinal nerve involvement in early GBS: a frequent finding in nerve US 
Spinal magnetic resonance imaging (MRI) studies have demonstrated in the great 
majority of early GBS patients contrast enhancement and thickening of cauda equina, 















of MRI is that it is not always applicable in severe patients, particularly those under 
mechanical ventilation. Nerve US has emerged as promising technique in the diagnosis 
of peripheral nervous system disorders [61]. One advantage of nerve US is its 
applicability and repeatability even in severe patients. With colleagues, I carried out a 
prospective study in all consecutive early GBS patients, admitted in our Hospital over 
one year [62]. The series comprised six GBS patients, four categorized as AIDP and the 
remaining two as AMSAN. Patient’s ages ranged from 37 to 80 years. Five patients 
required mechanical ventilation, two of them having died, 9 and 28 days after onset. US 
protocol included scanning of representative nerves of upper and lower limbs. Since the 
brunt of pathology may rely on spinal nerves (vide supra), we also scanned ventral rami 
of C5-C7 nerves. Upper and lower limb nerve sonograms showed abnormal findings in 
just 9% of scanned peripheral nerves. Conversely, US of the fifth to seventh cervical 
nerves showed abnormal features in 4 (67%) of cases consisting of nerve enlargement, 
blurred boundaries of the corresponding ventral rami, or both (Fig. 6). Such features are 
in good correlation with our autopsy study showing evident endoneurial inflammatory 
oedema extending to the epi-perineurium (Fig. 7). Furthermore, we have reported 
similar US findings in an AMAN patient presenting with paraparetic GBS [63]. Our US 
cervical nerve findings have been replicated by others [64-66]. 
 
11. Final comments and conclusions 
Corroborating pathological findings by Haymaker and Kernohan [1], our US and 
histological studies have demonstrated that inflammatory changes of ventral rami of 
spinal nerves may be a glaring feature in early GBS. Figure 4 summarizes our 
pathogenic proposals for early stages of GBS. Severe inflammatory oedema of ventral 















double consequence: i/ loss of hyperechoic epineurial rim as a result of epineurial 
inflammation; and ii/ a compressive effect with variable increase of cross sectional area, 
which would imply an increase of EFP that stretches the perineurium constricting the 
transperineurial microcirculation, compromising blood flow and producing potential 
ischemic injury [59]. Such ischemic injury could induce failure in proximal conduction 
manifested with abnormal late electrophysiological responses and relative preservation 
of motor and sensory conduction velocities. This mechanism helps explain the 
pathogenesis of GBS cases with severe paralysis and short-lived clinical course whose 
autopsy studies, not including spinal nerves, showed no prominent structural changes 
along the nerve [17], and cases with demonstrated early attenuated M responses after 
electrical root stimulation and preserved conventional electrophysiological studies [67]. 
Concerning early AMAN/AMSAN, we have proposed that there may be a dual 
mechanism of muscle weakness: distal motor conduction block induced by 
antiganglioside antibodies, and proximal conduction block induced by inflammatory 
oedema [57]. Accepting the pathogenic role of endoneurial oedema in the first few days 
of the clinical course, there is a pressing need for new therapeutic strategies to stop its 
rapid impact on the axons, which in EAN appears at the height of the inflammatory 
process at 7 days immunogen postinoculation [59, 68]. 
Other outstanding Haymaker and Kernohan’s contributions were to clarify the 
complex nosology of GBS bringing under the same rubric Landry’s paralysis, AFP and 
GBS, and critically analyzing the GBS exclusion criteria by then prevailing. 
 
12. Postcript: Haymaker’s and Kernohan’s obituaries  
As renowned authorities in the field of neurology and neuropathology, Webb Edward 















laudatory obituaries [69-71]. Neither Sayre [69, 70] nor Earle [71] mentioned the 
immense contribution of the authors to GBS. It is a shame because Haymaker and 
Kernohan’s findings, as proven here, play an irreplaceable role to understanding the 
physiopathology of early GBS. 
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Figure 1. Reproduction of figures 65 to 67 by Krücke [48] with minimal 
modifications. (A) Diagram of GBS lesions at cervical (upper row), thoracic (middle 
row) and sacral (lower row) levels; note that they mainly rely on proximal nerves 
including ventral and dorsal spinal roots, spinal root ganglia, sympathetic ganglia and 
ventral rami of spinal nerves (red dots). Lettering b-c indicates nerve segment illustrated 
in the following two figures. (B) Longitudinal section of the nerve segment between 
ventral spinal root and spinal nerve from a GBS patient who died on day 18, original 
numbering being as follows: (1 and 2) areas illustrated by the author in other figures 
(specially his figure 68b showing abundant endoneurial inflammatory oedema, which 
was designated as “mucoid exudate”); (3) rami of the spinal nerve (undoubtedly, ventral 
and dorsal rami); (4) spindle-shaped swelling of the spinal nerve; (5) spinal root 
ganglion; and (6) ventral spinal root (Van Gieson, magnification not specified). (C) The 
same longitudinal section showing a purplish discoloration of the spindle-shaped 
swelling of the spinal nerve (Cresyl violet, magnification not specified). 
 
Figure 2. Reproduction of figure 68 by Krücke [48]. This figure includes two 
sections of spinal nerve (see lettering b-c in figure 1A). (A) Focal inflammatory 
infiltrates with preservation of myelinated fibres (Heindenhain-Wolcke, magnification 
not specified). (B) Extensive “mucoid” exudate separating myelinated fibres, which 


















Figure 3. Pathology in fulminant GBS with universal nerve inexcitability. (A) 
Semithin section of L5 ventral root showing massive demyelination and numerous lipid-
laden macrophages (Toluidine blue; x630 before reduction). (B) Semithin section of 
femoral nerve illustrating marked axonal degeneration (asterisks). Note the presence of 
denuded axons (arrows), and endoneurial and subperineurial macrophage infiltrates 
(Toluidine blue, x630 before reduction). Taken from Berciano et al. [51]. 
 
Figure 4. Diagram of spinal root and spinal nerve microscopic anatomy. As of 
subaracnoid angle (SA), the epineurium (Ep) is in continuity with the dura mater (DM). 
The endoneurium (En) persists from the peripheral nerves through the spinal roots to 
their junction with the spinal cord. At the SA, the greater portion of the perineurium 
(Pe) passes between the dura and the arachnoid (Ar), but a few layers appear to continue 
over the roots as the inner layer of the root sheath (RS). The arachnoid is reflected over 
the roots at the SA and becomes continuous with the external layers of the RS. At the 
junction with the spinal cord, the outer layers become continuous with the pia mater 
(PM). Immediately beyond the spinal ganglion (SG), at the SA, the ventral and dorsal 
nerve roots unite to form the spinal nerve, which emerges through the intervertebral 
foramen and divides into a dorsal ramus (DRSN) and a ventral ramus (VRSN). 
Therefore intrathecal nerve roots are covered by an elastic root sheath derived from the 
arachnoid, whereas spinal nerves possess epi-perineurium which is relatively inelastic. 
Proximal-to-distal early GBS inflammatory lesions are illustrated as follows: ventral 
lumbar root (level 1), spinal nerve (level 2) and sciatic nerve (level 3). At level 1, this 
semithin complete cross section of ventral L5 root shows preservation of the density 
myelinated fibres (1A), though inflammatory lesions, observable at higher augmentation 















enhancement of ventral roots on spinal MRI (1B, arrows). Both cartoons at level 2 
illustrate the following features: i/ normal anatomy of spinal nerve, usually 
monofascicular with epi-perineurial covering (2A), which account for its sonographic 
appearance usually consisting of a hypoechoic oval structure surrounded by hyperechoic 
perineurial rim; and ii/ endoneurial inflammatory oedema may cause a critical elevation 
in EFP that constricts transperineurial vessels by stretching the perineurium beyond the 
compliance limits (2B, arrowheads), which could result in areas of endoneurial 
ischemia, here centrofascicular. As illustrated here (2A vs 2B), despite low spinal nerve 
compliance, early inflammatory events in GBS may cause an increase of cross sectional 
area; moreover, perineurial inflammation accounts for loss of hyperechoic perineurial 
rim. At level 3, this cross semithin section of sciatic nerve from a fatal AIDP patient 
shows several myelinated fibres exhibiting wallerian- like degeneration (myelin 
collapse, arrows) secondary to more proximal demyelinating lesions; note the presence 
of remyelinated fibers (arrowheads) and lipid-laden macrophages. Without knowledge 
of proximal nerve pathology, such distal florid wallerian- like lesions would make it 
very difficult to reach an accurate diagnosis. Diagram inspired by figure 3-6 from 
Berthold et al. [58]. Taken from Berciano et al. [57]. 
 
Figure 5. Proximal nerve ischemic lesions in AIDP. (A) Semithin cross-section of the 
third lumbar nerve showing a wedge-shape area (arrows) with marked loss of 
myelinated fibres (Toluidine blue; x62 before reduction). (B) Semithin cross-section of 
the lumbosacral trunk with a centrofascicular area (arrows) also exhibiting marked loss 
of myelinated fibres (Toluidine blue; x62 before reduction). Both in A and B note 
apparent widespread diminution of myelinated fibers. (C) This high-power view of the 















fibres, thinly myelinated small axons, preserved unmyelinated axons (arrowheads), and 
widespread endoneurial mononuclear inflammatory cells, some of them with 
perivascular distribution (arrows) (Toluidine blue; x375 before reduction). (D) This 
high-power view of the subperineurial region of the lumbosacral trunk shows numerous 
de-remyelinated fibers and mononuclear cells; such extensive demyelination accounts, 
to some degree, for the apparent widespread loss of myelinated fibers observed in A and 
B (Toluidine blue; x475 before reduction). Taken from Berciano et al. [52]. 
 
Figure 6. Cervical nerve US in a severe AIDP patient. US study in this 80-year-old 
patient was done on day 5 after onset. For pathological data of ventral rami of C6 nerve 
see figure 1 in Gallardo et al [62]. (A) Sagittal sonogram showing blurred boundaries of 
the 3 scanned cervical nerves (callipers). Asterisks indicate transverse vertebral 
processes. (B-D) Short-axis sonograms showing the cross sectional area of each cervical 
nerve (dotted green tracings; for values see Gallardo et al. [62]); note that perineurial 
hyperechoic rims are not identified and that the edge between the nerve and the 
surrounding fat is not clear. CC indicates common carotid artery. Taken from Gallardo 
et al. [62]. 
 
Figure 7. L5 root and fifth lumbar nerve in a severe AIDP patient. This is the 
patient whose nerve US is illustrated in Fig. 6; she died 9 days after onset. (A) After 
being dissected down, macroscopic appearance of the right L5 spinal root, L5 spinal 
ganglion and fifth lumbar spinal nerve. Whereas the preforaminal root shows normal 
morphology, as of the vertebral foramen (VF) note visible nerve enlargement (for 
comparison, see Fig. 1B, C). (B) Semithin cross-section of L5 ventral root, taken 1 cm 















(Toluidine blue; original magnification x100 before reduction). (C) Semithin cross-
section of the ventral ramus of the fifth lumbar nerve, taken at its emergence trough 
intervertebral foramen, showing widespread endoneural oedema, which is more 
conspicuous in some subperineurial areas (arrows and arrowheads); such oedema results 
in a spacing out phenomenon giving an observer the false impression of reduced density 
of myelinated fibres (Toluidine blue; original magnification x65 before reduction). (D) 
High-power view of the subperineurial area arrowed in B. Note the presence of 
inflammatory oedema with numerous mononuclear cells, fibres with inappropriately 
thin myelin sheaths (arrowhead), and fibres exhibiting myelin vacuolation (arrow) 
(Toluidine blue; original magnification x630 before reduction). (E) High-power view of 
the epi-perineurial and subperineurial area indicated with arrowheads in B. Conspicuous 
oedema is accompanied by the presence of endoneurial (arrow) and epi-perineurial 
(arrowhead) mononuclear cells (Toluidine blue; original magnification x630 before 


























































































































 The brunt of pathology in early Guillain-Barré syndrome (GBS) relies on spinal 
nerves (Haymaker and Kernohan, 1949). 
 The initial lesion is endoneurial oedema. 
 This patological pattern has been corroborated in further autopsy studies, and by 
means of nerve ultrasonography. 
 Spinal nerve involvement is a hotspot in early GBS, either demyelinating or 
axonal. 
 This notion is essential to understand its physiopathology. 
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